Thus, oligodendrogliomas and IDH-mutant astrocytomas of WHO grade II and III can be grouped under the low-grade glioma category, whereas glioblastomas and IDH wild-type astrocytomas, which share similar molecular phenotypes, belong to the high-grade glioma group [13•]. This evidence concerns the gene IDH2 and oligodendroglioma.